HHS nomination
This article was originally published in The Rose Sheet
Executive Summary
President Bush is nominating HHS General Counsel Alex Azar to serve as the department's deputy secretary. Azar will need to be confirmed by the Senate in order to assume the new role. He was previously approved by the chamber before becoming general counsel. Azar was a partner at Wiley, Rein & Fielding prior to joining the Bush Administration; he also clerked for Associate Supreme Court Justice Antonin Scalia. Azar would fill the vacancy left by former Deputy Secretary Claude Allen, who moved to the White House as a domestic policy advisor near the beginning of Bush's second term...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.